Even preceding the downturn there was a lack of enthusiasm for and confidence in biotechs. The lack of interest now is unsurprising considering that people these days are tending to jump at shadows and to lack enthusiasm for buying anything.
People will also be wondering how NEU will raise funds to bring Glypromate to market if the results are a success, so there are a couple of elements of uncertainty. However successful results will be fantastic.
NEU announced "top level efficacy results on track to be released in December 2008", so there are not too many days left to wait. I shouldn't be so impatient as the results are 6 months ahead of schedule.
http://www.neurenpharma.com/ssl/CMS/files_cms/NEU%20GPE%20Data%20Collection%20Nov%202008.pdf
M2
Even preceding the downturn there was a lack of enthusiasm for...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |